Sinocelltech Group (SHSE:688520) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688520 Sinocelltech Group Ltd SHSE:688520
54 GF Score
Price ¥33.76
GF Value ¥36.52
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sinocelltech Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sinocelltech Group's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:688520 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Sinocelltech Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinocelltech Group Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:688520
54GF Score
Sinocelltech Group Ltd SHSE:688520
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sinocelltech Group (SHSE:688520) Overvalued in 2026?

Based on GuruFocus' analysis, Sinocelltech Group stock appears to be undervalued. The current stock price of ¥33.76 is trading 7.6% below its estimated GF Value™ of ¥36.52. GuruFocus considers Sinocelltech Group to be Fairly Valued.

Key valuation signals for SHSE:688520:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥36.52 vs. price of ¥33.76 (7.6% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinocelltech Group Business Description

Address Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, No. 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is one of Chin's biopharma companies specializing in biologics and vaccines. The company's therapeutic areas include oncology, immunology and inflammation, ophthalmology, and prophylactic vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The capabilities of the company include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up, protein purification development, and large scale production.
54GF Score

Get the complete analysis for SHSE:688520

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥33.76
Price
¥36.52
GF Value